Skip to main content
. Author manuscript; available in PMC: 2018 Mar 8.
Published in final edited form as: Gynecol Oncol. 2016 Jun 11;142(2):341–348. doi: 10.1016/j.ygyno.2016.03.022

Table 2. Differential Expression of Potential Therapeutic Targets.

Fold-change values from microarray and qPCR are presented

Gene FNAR-C1
Microarray		 FNAR-C1
PCR		 SKOV3
Microarray		 SKOV3
PCR
RRAGD 3.467 2.309
ERBB2
(her-2/neu)		 −1.040 −1.147 1.320 1.308
CD47 2.088 1.961 1.827 2.079
FGF18 2.912 3.793 1.778 3.775

FNAR-C1 data are presented as ALDHhigh FNAR-C1 cells versus ALDHlow FNAR-C1 cells. SKOV3 data are presented as ALDHhigh Taxol-resistant SKOV3 cells versus ALDHlow SKOV3 cells. Empty cells signify that the gene was not tested with that assay.